EVMN

NYSE Evommune, Inc.
Oct 3, 2026 · 12:07 AM ET EOD Market Closed

$6.92 ↑ +0.00 (+0.00%) Trading Up from the previous close of $6.92, $0.36 below the day’s high of $7.28

YTD change
-59.58%
vs 20-day SMA
-29.18%
vs 200-day SMA
-63.57%

Price ranges

Previous day
$6.99 $8.30
open $8.24 close $7.21
-$1.03 (-12.50%)
Today
$6.74 $7.28
open $7.25 now $6.92
-$0.33 (-4.55%)
Past week
$6.99 $8.80
from $8.80 now $6.92
-$1.88 (-21.36%)
Past month
$6.99 $13.35
from $12.48 now $6.92
-$5.56 (-44.55%)
This year
$6.74 $33.20
from $17.12 now $6.92
-$10.20 (-59.58%)

Price & Performance

-16.80 (-70.83%) / 6M

$5.18$13.58$21.99$30.39Apr 2Jul 6Oct 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 79.2% away from all-time highs of $33.20
  • EVMN is down 60% since the beginning of the year
  • EVMN is down 66% over the past 12 months
  • EVMN is down 45% over the past 1 month
  • 14% of all EVMN investors are betting against EVMN
  • Number of investors short EVMN has gone down 34% versus last month

EVMN reads poor: price sits below both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is -65.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.89
Earnings momentum -6.0% Quarterly EPS growth
Quarterly change -6.0%

Valuation

P/E ratio N/A
Enterprise value $68.4M
Beta 1.08

Balance sheet & scale

IncomeN/A
Revenue$10.0M
Cash$200.8M
Debt$8.6K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $251.1M

Evommune, Inc. is a clinical-stage biotechnology company. It engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pena, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Palo Alto, CA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,142.85 -0.61%
JNJ Johnson & Johnson $256.03 -1.02%
ABBV AbbVie, Inc. $262.82 +1.11%
MRK Merck & Co., Inc. $144.30 +0.34%
RHHVF Roche Holding Ltd $428.22 -3.25%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.